By Nuvama Research
We recently met Pankaj Sahni, CEO of Global Health (Medanta). Key takeaways emerged: He expressed confidence in the increasing demand for healthcare services in the Delhi NCR. He noted that there is no immediate supply risk, but cautioned that not all healthcare chains may thrive in the market.
Medanta perceives significant growth opportunities in Delhi-NCR due to low bed density and the absence of credible competition. Similarly, in Lucknow and Central India, they see potential due to limited established competitors.
Management is not too worried about competitors and their expansion plans in Delhi-NCR. Given lower bed density (1.9x beds per 1,000 people versus 3x in other key geographies), growing population, uptick in international patients and lack of credible players, there is enough headroom to grow. Moreover, its strong brand puts it ahead in the league. Medanta plans to add 800 beds over FY23–25 in north India, taking its total bed capacity to 3,500. Of this, 800 beds would come up at existing hospitals: Lucknow (150–200), Patna (250) and Gurugram (100). The Noida hospital is likely to commence with 300 beds in FY25.